Peabody has until today to complete Due Dilligence. Maybe it reflects the market's view that Peabody offer may not proceed?ANZ
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025